SCHEMBL9611246

SCHEMBL9611246

CCCCCCCCCCCCCCCCCC(=O)OC(CO)COP(=O)(O)OCC[N+](C)(C)C

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 1/20 0.81
SMN1; SMN2 Q16637 2/20 0.63
NR5A2 O00482 1/20 0.63
NR5A1 Q13285 1/20 0.63
RECQL P46063 1/20 0.59
S1PR1 P21453 1/20 0.56
PRKCA P17252 1/20 0.55
PRKCE Q02156 1/20 0.55
PRKCQ Q04759 1/20 0.55
PRKCD Q05655 1/20 0.55
MAPT P10636 2/20 0.55
LPAR3 Q9UBY5 5/20 0.55
LPAR1 Q92633 4/20 0.55
LPAR6 P43657 1/20 0.55
LPAR4 Q99677 1/20 0.55
LPAR5 Q9H1C0 1/20 0.55
LPAR2 Q9HBW0 1/20 0.55
MAPK1 P28482 1/20 0.55
ENPP2 Q13822 1/20 0.53
SELP P16109 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28505996 1.00 FABP3 (0.81) FABP3SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL31106468 1.00 FABP3 (0.81) FABP3SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL30605184 1.00 FABP3 (0.81) FABP3SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL31362195 1.00 FABP3 (0.81) FABP3SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL21680883 1.00 FABP3 (0.81) FABP3SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL28505997 1.00 FABP3 (0.81) FABP3SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL30842177 1.00 FABP3 (0.81) FABP3SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL31425003 1.00 FABP3 (0.81) FABP3SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL31400386 1.00 FABP3 (0.81) FABP3SMN1; SMN2NR5A2NR5A1RECQL
SCHEMBL31497281 0.99 FABP3 (0.80) FABP3SMN1; SMN2NR5A2NR5A1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250319190-A1 APOE LIPOPROTEIN SYSTEMS KISBEE THERAPEUTICS INC (US) 2025-10-16 US disclosed
WO-2023220387-A2 APOE LIPOPROTEIN SYSTEMS KISBEE THERAPEUTICS, INC. (US) 2023-11-16 WO disclosed
US-20230136465-A1 PLANT-BASED CHICKEN FLAVORING AGENT COMPOSITION NotCo Delaware AI, LLC 2023-05-04 US disclosed
US-8657943-B2 1-hydroxy-2-O-acyl-sn-glycero-3-phosphocholine compounds, preparation process, antifouling composition, process for its preparation, method to prevent fouling, method to turn a surface into an antifouling surface, and, covered surface UFRJ, IEAPM, UFF (BR) 2014-02-25 US disclosed
US-20120135134-A1 1-HYDROXY-2-O-ACYL-SN-GLYCERO-3-PHOSPHOCHOLINE COMPOUNDS, PREPARATION PROCESS, ANTIFOULING COMPOSITION, PROCESS FOR ITS PREPARATION, METHOD TO PREVENT FOULING, METHOD TO TURN A SURFACE INTO AN ANTIFOULING SURFACE, AND, COVERED SURFACE UNIVERSIDADE FEDERAL DO RIO DE JANEIRO - UFRJ (BR) 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250319190-A1 APOE LIPOPROTEIN SYSTEMS APOB, APOL1, LDLR FABP3 20/4885SMN1; SMN2 1150/4885NR5A2 2095/4885
US-20120135134-A1 1-HYDROXY-2-O-ACYL-SN-GLYCERO-3-PHOSPHOCHOLINE COMPOUNDS, PREPARATION PROCESS, ANTIFOULING COMPOSITION, PROCESS FOR ITS PREPARATION, METHOD TO PREVENT FOULING, METHOD TO TURN A SURFACE INTO AN ANTIFOULING SURFACE, AND, COVERED SURFACE PHOSPHO1, MBOAT1, ABHD5 FABP3 826/4885SMN1; SMN2 4269/4885NR5A2 2989/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.